1
|
Requirement of bic/microRNA-155 for normal immune function.
|
Science
|
2007
|
16.24
|
2
|
Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.
|
Science
|
2009
|
7.80
|
3
|
Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking.
|
Nat Immunol
|
2008
|
4.69
|
4
|
Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice.
|
FASEB J
|
2007
|
3.83
|
5
|
Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation.
|
Nature
|
2006
|
3.71
|
6
|
Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage.
|
Science
|
2013
|
3.33
|
7
|
The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
|
Proc Natl Acad Sci U S A
|
2008
|
2.81
|
8
|
Essential role for the p110delta phosphoinositide 3-kinase in the allergic response.
|
Nature
|
2004
|
2.73
|
9
|
PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
|
J Exp Med
|
2012
|
2.58
|
10
|
Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.
|
J Immunol
|
2009
|
2.51
|
11
|
Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils.
|
Blood
|
2005
|
2.35
|
12
|
Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.
|
J Immunol
|
2006
|
2.29
|
13
|
Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.
|
Immunity
|
2011
|
2.17
|
14
|
The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development.
|
Sci Signal
|
2010
|
2.15
|
15
|
Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells.
|
Blood
|
2005
|
2.05
|
16
|
P-Rex1 regulates neutrophil function.
|
Curr Biol
|
2005
|
1.97
|
17
|
PI3Kβ plays a critical role in neutrophil activation by immune complexes.
|
Sci Signal
|
2011
|
1.95
|
18
|
Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing.
|
J Immunol
|
2004
|
1.81
|
19
|
PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.
|
Blood
|
2010
|
1.76
|
20
|
Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.
|
J Immunol
|
2010
|
1.63
|
21
|
CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer.
|
Blood
|
2007
|
1.60
|
22
|
MAPK, phosphatidylinositol 3-kinase, and mammalian target of rapamycin pathways converge at the level of ribosomal protein S6 phosphorylation to control metabolic signaling in CD8 T cells.
|
J Immunol
|
2009
|
1.42
|
23
|
Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation.
|
Blood
|
2007
|
1.27
|
24
|
Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation.
|
Eur J Immunol
|
2007
|
1.23
|
25
|
Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28.
|
Blood
|
2007
|
1.20
|
26
|
CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway.
|
Blood
|
2009
|
1.14
|
27
|
A two-signal model for T cell trafficking.
|
Trends Immunol
|
2007
|
1.13
|
28
|
T cell receptor-induced phosphoinositide-3-kinase p110delta activity is required for T cell localization to antigenic tissue in mice.
|
J Clin Invest
|
2008
|
1.13
|
29
|
The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells.
|
J Immunol
|
2009
|
1.12
|
30
|
Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance.
|
Proc Natl Acad Sci U S A
|
2010
|
1.11
|
31
|
Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages.
|
J Biol Chem
|
2003
|
1.11
|
32
|
The PI3K p110δ regulates expression of CD38 on regulatory T cells.
|
PLoS One
|
2011
|
1.10
|
33
|
Firefly luciferin-activated rose bengal: in vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells.
|
Cancer Res
|
2003
|
1.01
|
34
|
Cross talk between phosphatidylinositol 3-kinase and cyclic AMP (cAMP)-protein kinase a signaling pathways at the level of a protein kinase B/beta-arrestin/cAMP phosphodiesterase 4 complex.
|
Mol Cell Biol
|
2010
|
1.01
|
35
|
Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.
|
J Allergy Clin Immunol
|
2008
|
1.00
|
36
|
p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease.
|
Proc Natl Acad Sci U S A
|
2009
|
1.00
|
37
|
Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.
|
J Immunol
|
2012
|
0.97
|
38
|
The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.
|
Open Rheumatol J
|
2012
|
0.97
|
39
|
Blockade of phosphatidylinositol 3-kinase PI3Kδ or PI3Kγ reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis.
|
J Immunol
|
2012
|
0.96
|
40
|
Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts.
|
PLoS One
|
2012
|
0.94
|
41
|
CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway.
|
J Immunol
|
2005
|
0.93
|
42
|
Does the PI3K pathway promote or antagonize regulatory T cell development and function?
|
Front Immunol
|
2012
|
0.91
|
43
|
Gene-targeting reveals physiological roles and complex regulation of the phosphoinositide 3-kinases.
|
Arch Biochem Biophys
|
2003
|
0.89
|
44
|
Requirement for phosphoinositide 3-kinase p110delta signaling in B cell antigen receptor-mediated antigen presentation.
|
J Immunol
|
2007
|
0.89
|
45
|
Gene targeting in mice: a review.
|
Methods Mol Biol
|
2013
|
0.88
|
46
|
IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells.
|
J Immunol
|
2014
|
0.87
|
47
|
Role of the p110delta PI 3-kinase in integrin and ITAM receptor signalling in platelets.
|
Platelets
|
2005
|
0.85
|
48
|
Proliferative signals mediated by CD28 superagonists require the exchange factor Vav1 but not phosphoinositide 3-kinase in primary peripheral T cells.
|
Eur J Immunol
|
2008
|
0.81
|
49
|
The transcription factor BACH2 promotes tumor immunosuppression.
|
J Clin Invest
|
2016
|
0.78
|
50
|
A protocol for construction of gene targeting vectors and generation of homologous recombinant embryonic stem cells.
|
Methods Mol Biol
|
2013
|
0.76
|
51
|
PI3K p110δ is expressed by gp38(-)CD31(+) and gp38(+)CD31(+) spleen stromal cells and regulates their CCL19, CCL21, and LTβR mRNA levels.
|
PLoS One
|
2013
|
0.75
|
52
|
Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
|
Nature
|
2016
|
0.75
|